Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

5-Amino-1MQ vs Tirzepatide

5-Amino-1MQ and Tirzepatide are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassSmall-molecule NNMT inhibitor (methylquinolinium salt) — not a peptideLipidated dual receptor agonist (GIP / GLP-1), 39-residue chain
Molecular weightNot specified4813.5 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasMetabolic, Cellular LongevityMetabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for several weeks at 2-8 °C in preserved diluent.Commonly worked with for 4–6 weeks at 2–8 °C.
Lead degradation routeMicrobial growth in non-preserved diluent — a container problem rather than a molecular one.Interfacial aggregation from agitation or freezing — the dominant practical route.
Freeze–thawTolerant of freeze-thaw — there is no tertiary structure to lose. Aliquoting is still good practice to limit repeated exposure of the stock.Do not freeze reconstituted solution. Interfacial aggregation during freezing is the characteristic failure mode and is irreversible.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: 5-Amino-1MQ is small-molecule nnmt inhibitor (methylquinolinium salt) — not a peptide, while Tirzepatide is lipidated dual receptor agonist (gip / glp-1), 39-residue chain — different molecular classes with different handling consequences; their leading degradation routes differ (microbial growth in non-preserved diluent for 5-Amino-1MQ, interfacial aggregation from agitation or freezing for Tirzepatide), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

5-Amino-1MQ — origin

5-Amino-1MQ is a small quinolinium molecule characterised as a first-in-class inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme studied at the intersection of adipocyte metabolism and the cellular NAD+/methylation pool. It is not an amino-acid chain, which is why it sits apart from every peptide in this catalogue.

Tirzepatide — origin

Tirzepatide is built on a GIP-based backbone rather than a GLP-1 one — an important and often-missed design detail. It was engineered from the GIP sequence and modified to acquire GLP-1 receptor activity, with a C20 fatty diacid attached via a linker for albumin binding. The term "twincretin" describes the dual incretin activity.

5-Amino-1MQ research themes

NNMT inhibition

The defining mechanism — preclinical work has examined how blocking NNMT shifts methylation flux and NAD+ salvage in metabolic tissue models.

Adipocyte energy metabolism

Studied in fat-cell models for effects on cellular energy handling and lipid metabolism.

NAD+ economy

Because NNMT consumes a methyl group tied to the NAD+ precursor pool, it is studied alongside the wider NAD+ research field.

Tirzepatide research themes

Dual incretin engagement

Simultaneous GIP and GLP-1 receptor activity from a GIP-derived backbone.

Insulin secretion and glucagon suppression

Core metabolic research endpoints for the incretin class.

Gastric emptying

A well-characterised GLP-1 pathway effect studied in metabolic models.

GIP receptor pharmacology

Whether GIP agonism or antagonism is the productive direction remains an active research debate.

5-Amino-1MQ handling

  • Let the sealed vial reach room temperature before opening so moisture does not condense onto the powder.
  • For cell-based assays, prepare a concentrated DMSO stock and dilute into aqueous buffer rather than dissolving directly at high concentration in medium.
  • Label aliquots with reconstitution date and diluent.

Tirzepatide handling

  • Swirl, never shake or vortex.
  • Add diluent down the vial wall and give the cake time — several minutes of slow dissolution is normal, not a defect.
  • Store upright and refrigerated; do not freeze once reconstituted.

Both third-party tested

Every Popular Peptides batch of 5-Amino-1MQ and Tirzepatide is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

5-Amino-1MQ reference

Full 5-Amino-1MQ reference 5-Amino-1MQ storage 5-Amino-1MQ reconstitution 5-Amino-1MQ calculator5-Amino-1MQ product details

Tirzepatide reference

Full Tirzepatide reference Tirzepatide storage Tirzepatide reconstitution Tirzepatide calculatorTirzepatide product details

Related comparisons

5-Amino-1MQ vs CJC-1295 (No DAC)5-Amino-1MQ vs CJC-1295 + Ipamorelin5-Amino-1MQ vs DSIP5-Amino-1MQ vs Epitalon5-Amino-1MQ vs GLOW5-Amino-1MQ vs IGF-15-Amino-1MQ vs IGF-1 LR35-Amino-1MQ vs Ipamorelin

5-Amino-1MQ and Tirzepatide are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.